Yüklüyor......
Do single‐arm trials have a role in drug development plans incorporating randomised trials?
Often, single‐arm trials are used in phase II to gather the first evidence of an oncological drug's efficacy, with drug activity determined through tumour response using the RECIST criterion. Provided the null hypothesis of ‘insufficient drug activity’ is rejected, the next step could be a rand...
Kaydedildi:
| Yayımlandı: | Pharm Stat |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley and Sons Inc.
2015
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4855632/ https://ncbi.nlm.nih.gov/pubmed/26609689 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pst.1726 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|